EMA CHMP provides positive opinion for ViiV’s cabotegravir
The EMA CHMP has provided a positive opinion recommending grant of marketing authorisation to ViiV Healthcare’s cabotegravir.
The EMA CHMP has provided a positive opinion recommending grant of marketing authorisation to ViiV Healthcare’s cabotegravir.
What's Your Reaction?
